INmune Bio Inc. (INMB)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
9.10
1.08 (13.47%)
At close: Jan 29, 2025, 3:59 PM
9.20
1.10%
After-hours Jan 29, 2025, 07:45 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
PE Ratio | -6.75 | -3.97 | -5.42 | -17.06 | -6.52 | -7.21 | -107.81 | -323.05 | -1.83K |
PS Ratio | 1.31K | 303.90 | 909.01 | 18.91K | 0.77 | n/a | n/a | n/a | n/a |
PB Ratio | 5.31 | 1.89 | 2.05 | 5.33 | 2.52 | 5.42 | 4.95 | -600.81 | -4.75K |
P/FCF Ratio | -16.9 | -5.01 | -3.78 | -23.08 | -11.07 | -43.54 | -104.01 | -282.45 | -4.95K |
P/OCF Ratio | -16.9 | -5.01 | -5.77 | -23.08 | -11.07 | -43.54 | -117.67 | -282.45 | -4.95K |
OCF/S Ratio | -77.29 | -60.66 | -157.48 | -819.32 | -0.07 | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.27 | 0.25 | 0.19 | 0.00 | 0.01 | n/a | n/a | -2.35 | n/a |
Quick Ratio | 2.16 | 5.92 | 20.21 | 1.15K | 1.11K | 1.03 | 6.13 | 0.75 | 0.39 |
Current Ratio | 2.16 | 5.92 | 18.95 | 13.50 | 11.09 | 1.03 | 6.13 | 0.75 | 0.39 |
Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 3.17 | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | -19.25 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity (ROE) | -0.79 | -0.48 | -0.38 | -0.31 | -0.39 | -0.75 | -0.05 | 1.86 | 2.59 |
Return on Assets (ROA) | -0.53 | -0.35 | -0.3 | -0.3 | -0.37 | -0.72 | -0.05 | -0.61 | -4.11 |
Return on Capital (ROIC) | -0.77 | -0.37 | -0.3 | -0.31 | -0.33 | -0.75 | -0.05 | 1.52 | 2.59 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | n/a | n/a | n/a | n/a |
Net Profit Margin | -19.36K% | -7.66K% | -16.76K% | -110.84K% | -11.77% | n/a | n/a | n/a | n/a |
Pretax Profit Margin | -19.36K% | -7.30K% | -16.76K% | -110.84K% | -9.88% | n/a | n/a | n/a | n/a |
Operating Profit Margin | -19.19K% | -6.94K% | -16.11K% | -112.02K% | -9.98% | n/a | n/a | n/a | n/a |
FCF Margin | -7.73K% | -6.07K% | -24.04K% | -81.93K% | -6.93% | n/a | n/a | n/a | n/a |
EBITDA Margin | -19.19K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |